HYPERINSULINEMIA, SEX, AND RISK OF ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE

被引:82
|
作者
MODAN, M
OR, J
KARASIK, A
DRORY, Y
FUCHS, Z
LUSKY, A
CHETRIT, A
HALKIN, H
机构
[1] CHAIM SHEBA MED CTR,DEPT MED,IL-52621 TEL HASHOMER,ISRAEL
[2] CHAIM SHEBA MED CTR,DEPT CARDIAC REHABIL,IL-52621 TEL HASHOMER,ISRAEL
[3] TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL
关键词
GLUCOSE INTOLERANCE; OBESITY; HYPERTENSION; LIPOPROTEINS;
D O I
10.1161/01.CIR.84.3.1165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The possibility that hyperinsulinemia may be involved in the etiology of atherosclerotic cardiovascular disease (CVD) was first suggested 20 years ago. During the last decade, this possibility has received support from three large prospective studies. Methods and Results. In the present study, the association between CVD, glucose intolerance, obesity, and hypertension (the GOH conditions) and hyperinsulinemia was examined cross-sectionally in a representative sample (n = 1,263) of the adult Jewish population aged 40-70 years in Israel. Previously known diabetics were excluded. CVD comprising clinical or ECG evidence of ischemic heart disease, as well as clinical evidence of cerebrovascular or peripheral vascular disease, was identified in 97 men and 39 women. A significant (p < 0.01) hyperinsulinemia-sex interaction was found for CVD rate, with the adjusted risk ratios (followed by 95% confidence limits), relative to the rate in 298 normoinsulinemic women, being 1.15 (0.68-1.95) in 328 normoinsulinemic men, 0.85 (0.48-1.49) in 277 hyperinsulinemic women, and 2.27 (1.33-3.08) in 360 hyperinsulinemic men. Age-adjusted CVD rates in men versus women were: a) similar and low among all normoinsulinemic normotensives and hyperinsulinemics free of any of the GOH conditions (all rates less-than-or-equal-to 6.5%); b) similar and high among normoinsulinemic hypertensives (13.4% versus 10.4%); c) significantly higher in men among hyperinsulinemic normotensives with glucose intolerance and/or obesity (15.2% versus 3.3%; p = 0.02) and all hyperinsulinemic hypertensives (21.5% versus 12.8%; p = 0.04). These trends remained significant after adjusting for age, ethnic group, and blood lipids. Conclusions. Therefore, hyperinsulinemia was associated with excess CVD risk in men but not in women, and all excess CVD risk in men was confined to hyperinsulinemic individuals in the presence of glucose intolerance, obesity, or hypertension.
引用
收藏
页码:1165 / 1175
页数:11
相关论文
共 50 条
  • [1] HYPERINSULINEMIA, SEX, AND RISK OF ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    WILD, RA
    COWAN, LD
    CIRCULATION, 1992, 85 (05) : 1957 - 1958
  • [2] ATHEROSCLEROTIC RISK-FACTORS IN CARDIOVASCULAR-DISEASE
    LAROSA, JC
    JOURNAL OF REPRODUCTIVE MEDICINE, 1986, 31 (09) : 906 - 912
  • [3] RISK OF ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE IN MALE PROFESSIONALS IN SANTIAGO
    CHAMORRO, G
    ARTEAGA, A
    CASANEGRA, P
    RODRIGUEZ, JA
    MUNOZ, M
    MAIZ, A
    KUNSTMANN, S
    GONZALEZ, A
    COSTA, AM
    REVISTA MEDICA DE CHILE, 1983, 111 (10) : 1009 - 1017
  • [5] Fasting hyperinsulinemia, an independent risk factor for atherosclerotic cardiovascular disease.
    Glueck, CJ
    Lang, JE
    Tracy, T
    Sieve-Smith, L
    Wang, P
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (07) : 284A - 284A
  • [6] ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE - CURRENT PROSPECTIVES
    GOTTO, AM
    YESHURUN, D
    DEBAKEY, ME
    JOURNAL OF CHRONIC DISEASES, 1976, 29 (11): : 677 - 681
  • [7] SEX-HORMONES, RISK-FACTORS AND CARDIOVASCULAR-DISEASE
    PHILLIPS, GB
    AMERICAN JOURNAL OF MEDICINE, 1978, 65 (01): : 7 - 11
  • [8] BODY-FAT DISTRIBUTION AND HYPERINSULINEMIA AS RISK-FACTORS FOR DIABETES AND CARDIOVASCULAR-DISEASE
    STERN, MP
    HAFFNER, SM
    ARTERIOSCLEROSIS, 1986, 6 (02): : 123 - 130
  • [9] LIPOPROTEIN DISORDERS AS RELATED TO ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    SCANU, AM
    SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (04) : 557 - 567
  • [10] HOMOCYSTEINEMIA, AN INDEPENDENT, TREATABLE RISK FACTOR FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE IN HYPERLIPIDEMIC PATIENTS
    GLUECK, CJ
    SHAW, P
    WANG, Y
    LANG, J
    TRACY, T
    SIEVESMITH, L
    CLINICAL RESEARCH, 1994, 42 (03): : A359 - A359